Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Net Sales
318.23
368.59
Other Operating Income
0.00
0.00
Total Operating income
318.23
368.59
Raw Material Cost
170.56
224.76
Purchase of Finished goods
18.33
10.65
(Increase) / Decrease In Stocks
-21.52
9.10
Employee Cost
40.59
39.07
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
74.44
67.62
Total Expenditure (Excl Depreciation)
282.40
351.20
Operating Profit (PBDIT) excl Other Income
35.83
17.39
Other Income
0.50
0.10
Operating Profit (PBDIT)
36.33
17.49
Interest
14.93
13.92
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
21.40
3.57
Depreciation
16.61
14.65
Profit Before Tax
4.79
-11.07
Tax
-1.93
-2.00
Provisions and contingencies
0.00
0.00
Profit After Tax
6.72
-9.07
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
6.72
-9.07
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
6.72
-9.07
Equity Capital
15.83
15.83
Face Value
10.0
10.0
Reserves
126.07
119.96
Earnings per share (EPS)
4.25
-5.73
Diluted Earnings per share
4.25
-5.73
Operating Profit Margin (Excl OI)
11.28%
4.73%
Gross Profit Margin
6.74%
0.97%
PAT Margin
2.12%
-2.47%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -13.55% vs -0.77% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 176.46% vs -812.60% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 105.87% vs -32.41% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 7.26% vs 7.41% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Mangalam Drugs With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
318.23
25.47
292.76
1,149.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
318.23
25.47
292.76
1,149.43%
Raw Material Cost
170.56
10.17
160.39
1,577.09%
Purchase of Finished goods
18.33
0.00
18.33
(Increase) / Decrease In Stocks
-21.52
0.48
-22.00
-4,583.33%
Employee Cost
40.59
7.58
33.01
435.49%
Power Cost
0.00
1.68
-1.68
-100.00%
Manufacturing Expenses
0.00
1.37
-1.37
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
74.44
6.02
68.42
1,136.54%
Total Expenditure (Excl Depreciation)
282.40
27.30
255.10
934.43%
Operating Profit (PBDIT) excl Other Income
35.83
-1.83
37.66
2,057.92%
Other Income
0.50
2.73
-2.23
-81.68%
Operating Profit (PBDIT)
36.33
0.90
35.43
3,936.67%
Interest
14.93
0.02
14.91
74,550.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
21.40
0.88
20.52
2,331.82%
Depreciation
16.61
1.72
14.89
865.70%
Profit Before Tax
4.79
-0.84
5.63
670.24%
Tax
-1.93
-0.27
-1.66
-614.81%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
6.72
-0.57
7.29
1,278.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
6.72
-0.57
7.29
1,278.95%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.72
-0.57
7.29
1,278.95%
Equity Capital
15.83
12.47
3.36
26.94%
Face Value
10.00
10.00
0.00
Reserves
126.07
108.81
17.26
15.86%
Earnings per share (EPS)
4.25
-0.46
4.71
1,023.91%
Diluted Earnings per share
4.25
-0.46
4.71
1,023.91%
Operating Profit Margin (Excl OI)
11.28%
-7.21%
0.00
18.49%
Gross Profit Margin
6.74%
3.47%
0.00
3.27%
PAT Margin
2.12%
-2.25%
0.00
4.37%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 317.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -13.55% vs -0.77% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 6.92 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 176.46% vs -812.60% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 105.87% vs -32.41% in Mar 2024
Annual - Interest
Interest 14.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.26% vs 7.41% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.27%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
